Advertisement

Amino Acids

, Volume 45, Issue 6, pp 1373–1383 | Cite as

Wide distribution of CREM immunoreactivity in adult and fetal human brain, with an increased expression in dentate gyrus neurons of Alzheimer’s as compared to normal aging brains

  • Hans-Gert BernsteinEmail author
  • Elmar Kirches
  • Bernhard Bogerts
  • Uwe Lendeckel
  • Gerburg Keilhoff
  • Marina Zempeltzi
  • Johann Steiner
  • Klaus Tenbrock
  • Henrik Dobrowolny
  • Vasileios C. Kyttaris
  • Christian Mawrin
Original Article

Abstract

Human cyclic AMP response modulator proteins (CREMs) are encoded by the CREM gene, which generates 30 or more different CREM protein isoforms. They are members of the leucine zipper protein superfamily of nuclear transcription factors. CREM proteins are known to be implicated in a plethora of important cellular processes within the CNS. Amazingly, little is known about their cellular and regional distribution in the brain, however. Therefore, we studied by means of immunohistochemistry and Western blotting the expression patterns of CREM in developing and adult human brain, as well as in brains of Alzheimer’s disease patients. CREM immunoreactivity was found to be widely but unevenly distributed in the adult human brain. Its localization was confined to neurons. In immature human brains, CREM multiple neuroblasts and radial glia cells expressed CREM. In Alzheimer’s brain, we found an increased cellular expression of CREM in dentate gyrus neurons as compared to controls. We discuss our results with regard to the putative roles of CREM in brain development and in cognition.

Keywords

CREM Adult human brain Developing human brain Alzheimer’s disease Immunohistochemistry Western blot 

Abbreviations

Beta amyloid

AD

Alzheimer’s disease

Aka

Also known as

APP

Amyloid precursor protein

ATF

CREM/activating transcription factor

BA

Brodmann area

cAMP

Cyclic adenosine monophosphate

CNS

Central nervous system

CRE

cAMP response element

CREB

cAMP response element-binding protein

CREM

cAMP response element modulator

Da

Dalton

DG

Dentate gyrus

EDTA

Ethylene diamine tetraacetic acid

EGTA

Ethylene glycol tetraacetic acid

ICER

Inducible cAMP early repressor

IgG

Immunoglobulin G

LCD

Leucine-charged residue-rich domains

SDS

Sodium dodecyl sulfate

bZIP

Leucine zipper (protein superfamily)

Notes

Acknowledgments

The skillful technical work of Leona Bück, Ines Schellhase, Sandra Hartmann, Bianca Jerzykiewicz and Nadine Klappoth is highly appreciated.

Conflict of interest

The authors declare no conflict of interest.

References

  1. Aguado F, Díaz-Ruiz C, Parlato R, Martínez A, Carmona MA, Bleckmann S, Ureña JM, Burgaya F, del Río JA, Schütz G, Soriano E (2009) The CREB/CREM transcription factors negatively regulate early synaptogenesis and spontaneous network activity. J Neurosci 29:328–333PubMedCrossRefGoogle Scholar
  2. Ahlmann M, Varga G, Sturm K, Lippe R, Benedyk K, Viemann D, Scholzen T, Ehrchen J, Müller FU, Seidl M, Matus M, Tsokos GC, Roth J, Tenbrock K (2009) The cyclic AMP response element modulator alpha suppresses CD86 expression and APC function. J Immunol 182:4167–4174PubMedCrossRefGoogle Scholar
  3. Arendt T (2005) Alzheimer’s disease as a disorder of dynamic brain self-organization. Prog Brain Res 147:355–378PubMedCrossRefGoogle Scholar
  4. Avramopoulos D, Wang R, Valle D, Fallin MD, Bassett SS (2007) A novel gene derived from a segmental duplication shows perturbed expression in Alzheimer’s disease. Neurogenetics 8:111–120PubMedCrossRefGoogle Scholar
  5. Barcellos LF, May SL, Ramsay PP, Quach HL, Lane JA, Nititham J, Noble JA, Taylor KE, Quach DL, Chung SA, Kelly JA, Moser KL, Behrens TW, Seldin MF, Thomson G, Harley JB, Gaffney PM, Criswell LA (2009) High-density SNP screening of the major histocompatibility complex in systemic lupus erythematosus demonstrates strong evidence for independent susceptibility regions. PLoS Genet 5:e1000696PubMedCrossRefGoogle Scholar
  6. Behr R, Weinbauer GF (2000) CREM activator and repressor isoforms in human testis: sequence variations and inaccurate splicing during impaired spermatogenesis. Mol Hum Reprod 6:967–972PubMedCrossRefGoogle Scholar
  7. Bernstein HG, Schön E, Ansorge S, Röse I, Dorn A (1987) Immunolocalization of dipeptidyl aminopeptidase (DAP IV) in the developing human brain. Int J Dev Neurosci 5:237–242PubMedCrossRefGoogle Scholar
  8. Bernstein HG, Grecksch G, Becker A, Höllt V, Bogerts B (1999a) Cellular changes in rat brain areas associated with neonatal hippocampal damage. NeuroReport 10:2307–2311PubMedCrossRefGoogle Scholar
  9. Bernstein HG, Baumann B, Danos P, Diekmann S, Bogerts B, Gundelfinger ED, Braunewell KH (1999b) Regional and cellular distribution of neural visinin-like protein immunoreactivities (VILIP-1 and VILIP-3) in human brain. J Neurocytol 28:655–662PubMedCrossRefGoogle Scholar
  10. Bernstein HG, Smalla KH, Dürrschmidt D, Keilhoff G, Dobrowolny H, Steiner J, Schmitt A, Kreutz MR, Bogerts B (2012a) Increased density of prohibitin-immunoreactive oligodendrocytes in the dorsolateral prefrontal white matter of subjects with schizophrenia suggests extraneuronal roles for the protein in the disease. Neuromolecular Med 14:270–280PubMedCrossRefGoogle Scholar
  11. Bernstein HG, Stich C, Jäger K, Dobrowolny H, Wick M, Steiner J, Veh R, Bogerts B, Laube G (2012b) Agmatinase, an inactivator of the putative endogenous antidepressant agmatine, is strongly upregulated in hippocampal interneurons of subjects with mood disorders. Neuropharmacology 62:237–246PubMedCrossRefGoogle Scholar
  12. Blöcher S, Fink L, Bohle RM, Bergmann M, Steger K (2005) CREM activator and repressor isoform expression in human male germ cells. Int J Androl 28:215–223PubMedCrossRefGoogle Scholar
  13. Borsook D, Smirnova O, Behar O, Lewis S, Kobierski LA (1999) PhosphoCREB and CREM/ICER: positive and negative regulation of proenkephalin gene expression in the paraventricular nucleus of the hypothalamus. J Mol Neurosci 12:35–51PubMedCrossRefGoogle Scholar
  14. Chiappini F, Ramadoss P, Vella KR, Cunha LL, Ye FD, Stuart RC, Nillni EA, Hollenberg AN (2013) Family members CREB and CREM control thyrotropin-releasing hormone (TRH) expression in the hypothalamus. Mol Cell Endocrinol 365:84–94PubMedCrossRefGoogle Scholar
  15. Cortés-Mendoza J, Díaz de León-Guerrero S, Pedraza-Alva G, Pérez-Martínez L (2013) Shaping synaptic plasticity: the role of activity-mediated epigenetic regulation on gene transcription. Int J Dev Neurosci 31:359–369PubMedCrossRefGoogle Scholar
  16. Crisafulli C, Chiesa A, Han C, Lee SJ, Shim DS, Balzarro B, Andrisano C, Sidoti A, Patkar AA, Pae CU, Serretti A (2012) Possible influence of CREB1, CREBBP and CREM variants on diagnosis and treatment outcome in patients with schizophrenia. Neurosci Lett 508:37–41PubMedCrossRefGoogle Scholar
  17. De Felice FG, Wasilewska-Sampaio AP, Barbosa AC, Gomes FC, Klein WL, Ferreira ST (2007) Cyclic AMP enhancers and Abeta oligomerization blockers as potential therapeutic agents in Alzheimer’s disease. Curr Alzheimer Res 4:263–271PubMedCrossRefGoogle Scholar
  18. Della Fazia MA, Servillo G, Sassone-Corsi P (1997) Cyclic AMP signalling and cellular proliferation: regulation of CREB and CREM. FEBS Lett 410:22–24PubMedCrossRefGoogle Scholar
  19. Díaz-Ruiz C, Parlato R, Aguado F, Ureña JM, Burgaya F, Martínez A, Carmona MA, Kreiner G, Bleckmann S, Del Río JA, Schütz G, Soriano E (2008) Regulation of neural migration by the CREB/CREM transcription factors and altered Dab1 levels in CREB/CREM mutants. Mol Cell Neurosci 39:519–528PubMedCrossRefGoogle Scholar
  20. Domschke K, Kuhlenbäumer G, Schirmacher A, Lorenzi C, Armengol L, DiBella D, Gratacos M, Garritsen HS, Nöthen MM, Franke P, Sand P, Fritze J, Perez G, Maier W, Sibrowski W, Estivill X, Bellodi L, Ringelstein EB, Arolt V, Martin-Santos R, Catalano M, Stögbauer F, Deckert J (2003) Human nuclear transcription factor gene CREM: genomic organization, mutation screening, and association analysis in panic disorder. Am J Med Genet B Neuropsychiatr Genet 117B:70–78PubMedCrossRefGoogle Scholar
  21. Fenaroli A, Vujanac M, De Cesare D, Zimarino VA (2004) Small-scale survey identifies selective and quantitative nucleo-cytoplasmic shuttling of a subset of CREM transcription factors. Exp Cell Res 299:209–226PubMedCrossRefGoogle Scholar
  22. Fitzgerald LR, Vaidya VA, Terwilliger RZ, Duman RS (1996) Electroconvulsive seizure increases the expression of CREM (cyclic AMP response element modulator) and ICER (inducible cyclic AMP early repressor) in rat brain. J Neurosci 66:429–432Google Scholar
  23. Foulkes NS, Schlotter F, Pévet P, Sassone-Corsi P (1993) Pituitary hormone FSH directs the CREM functional switch during spermatogenesis. Nature 362(6417):264–267PubMedCrossRefGoogle Scholar
  24. Foulkes NS, Borjigin J, Snyder SH, Sassone-Corsi P (1996) Transcriptional control of circadian hormone synthesis via the CREM feedback loop. Proc Natl Acad Sci USA 93:14140–14145PubMedCrossRefGoogle Scholar
  25. Giedraitis V, Kilander L, Degerman-Gunnarsson M, Sundelöf J, Axelsson T, Syvänen AC, Lannfelt L, Glaser A (2009) Genetic analysis of Alzheimer’s disease in the Uppsala Longitudinal Study of Adult Men. Dement Geriatr Cogn Disord 27:59–68PubMedCrossRefGoogle Scholar
  26. Ginsberg SD, Elarova I, Ruben M, Tan F, Counts SE, Eberwine JH, Trojanowski JQ, Hemby SE, Mufson EJ, Che S (2004) Single-cell gene expression analysis: implications for neurodegenerative and neuropsychiatric disorders. Neurochem Res 29:1053–1064PubMedCrossRefGoogle Scholar
  27. Gomez-Villafuertes R, Torres B, Barrio J, Savignac M, Gabellini N, Rizzato F, Pintado B, Gutierrez-Adan A, Mellström B, Carafoli E, Naranjo JR (2005) Downstream regulatory element antagonist modulator regulates Ca2+ homeostasis and viability in cerebellar neurons. J Neurosci 25:10822–10830PubMedCrossRefGoogle Scholar
  28. Grupe A, Li Y, Rowland C, Nowotny P, Hinrichs AL, Smemo S, Kauwe JS, Maxwell TJ, Cherny S, Doil L, Tacey K, van Luchene R, Myers A, Wavrant-De Vrièze F, Kaleem M, Hollingworth P, Jehu L, Foy C, Archer N, Hamilton G, Holmans P, Morris CM, Catanese J, Sninsky J, White TJ, Powell J, Hardy J, O’Donovan M, Lovestone S, Jones L, Morris JC, Thal L, Owen M, Williams J, Goate A (2006) A scan of chromosome 10 identifies a novel locus showing strong association with late-onset Alzheimer disease. Am J Hum Genet 78:78–88PubMedCrossRefGoogle Scholar
  29. Hamilton SP, Slager SL, Mayo D, Heiman GA, Klein DF, Hodge SE, Fyer AJ, Weissman MM, Knowles JA (2004) Investigation of polymorphisms in the CREM gene in panic disorder. Am J Med Genet B Neuropsychiatr Genet 126B:111–115Google Scholar
  30. Herdegen T, Leah JD (1998) Inducible and constitutive transcription factors in the mammalian nervous system: control of gene expression by Jun, Fos and Krox, and CREB/ATF proteins. Brain Res Brain Res Rev 28:370–490PubMedCrossRefGoogle Scholar
  31. Hummler E, Cole TJ, Blendy JA, Ganss R, Aguzzi A, Schmid W, Beermann F, Schütz G (1994) Targeted mutation of the CREB gene: compensation within the CREB/ATF family of transcription factors. Proc Natl Acad Sci USA 91:5647–56451PubMedCrossRefGoogle Scholar
  32. Kadar E, Aldavert-Vera L, Huguet G, Costa-Miserachs D, Morgado-Bernal I, Segura-Torres P (2011) Intracranial self-stimulation induces expression of learning and memory-related genes in rat amygdala. Genes Brain Behav 10:69–77PubMedCrossRefGoogle Scholar
  33. Kim SH, Nairn AC, Cairns N, Lubec G (2001) Decreased levels of ARPP-19 and PKA in brains of Down syndrome and Alzheimer’s disease. J Neural Transm Suppl 61:263–272PubMedGoogle Scholar
  34. Konopka D, Szklarczyk AW, Filipkowski RK, Trauzold A, Nowicka D, Hetman M, Kaczmarek L (1998) Plasticity- and neurodegeneration-linked cyclic-AMP responsive element modulator/inducible cyclic-AMP early repressor messenger RNA expression in the rat brain. Neuroscience 86:499–510PubMedCrossRefGoogle Scholar
  35. Kwakowsky A, Herbison AE, Ábrahám IM (2012) The role of cAMP response element-binding protein in estrogen negative feedback control of gonadotropin-releasing hormone neurons. J Neurosci 32:11309–11337PubMedCrossRefGoogle Scholar
  36. Ledo F, Carrión AM, Link WA, Mellström B, Naranjo JR (2000) DREAM-alphaCREM interaction via leucine-charged domains derepresses downstream regulatory element-dependent transcription. Mol Cell Biol 20:9120–9126PubMedCrossRefGoogle Scholar
  37. Link WA, Ledo F, Torres B, Palczewska M, Madsen TM, Savignac M, Albar JP, Mellström B, Naranjo JR (2004) Day-night changes in downstream regulatory element antagonist modulator/potassium channel interacting protein activity contribute to circadian gene expression in pineal gland. J Neurosci 24:5346–5355PubMedCrossRefGoogle Scholar
  38. Luzzati F, De Marchis S, Parlato R, Gribaudo S, Schütz G, Fasolo A, Peretto P (2011) New striatal neurons in a mouse model of progressive striatal degeneration are generated in both the subventricular zone and the striatal parenchyma. PLoS One 6:e25088PubMedCrossRefGoogle Scholar
  39. Madsen HB, Navaratnarajah S, Farrugia J, Djouma E, Ehrlich M, Mantamadiotis T, Van Deursen J, Lawrence AJ (2012) CREB1 and CREB-binding protein in striatal medium spiny neurons regulate behavioural responses to psychostimulants. Psychopharmacology 219:699–713PubMedCrossRefGoogle Scholar
  40. Maldonado R, Smadja C, Mazzucchelli C, Sassone-Corsi P (1999) Altered emotional and locomotor responses in mice deficient in the transcription factor CREM. Proc Natl Acad Sci USA 96:14094–14099PubMedCrossRefGoogle Scholar
  41. Mantamadiotis T, Lemberger T, Bleckmann SC, Kern H, Kretz O, Martin VA, Tronche F, Kellendonk C, Gau D, Kapfhammer J (2002) Disruption of CREB function in brain leads to neurodegeneration. Nat Genet 31:47–54PubMedCrossRefGoogle Scholar
  42. Matsuzaki IK, Yamakuni T, Hashimoto M, Haque AM, Shido O, Mimaki Y, Sashida Y, Ohizumi Y (2006) Nobiletin restoring beta-amyloid-impaired CREB phosphorylation rescues memory deterioration in Alzheimer’s disease model. Neurosci Lett 400:230–234PubMedCrossRefGoogle Scholar
  43. Mellström B, Naranjo JR, Foulkes NS, Lafarga M, Sassone-Corsi P (1993) Transcriptional response to cAMP in brain: specific distribution and induction of CREM antagonists. Neuron 10:655–665PubMedCrossRefGoogle Scholar
  44. Nagy Z, Esiri MM, Cato AM, Smith AD (1997) Cell cycle markers in the hippocampus in Alzheimer’s disease. Acta Neuropathol 94:6–15PubMedCrossRefGoogle Scholar
  45. Naranjo JR, Mellström B, Carrion AM, Lucas JJ, Foulkes NS, Sassore-Corsi P (1997) Peripheral noxious stimulation induces CREM expression in dorsal horn: involvement of glutamate. Eur J Neurosci 9:2778–2793PubMedCrossRefGoogle Scholar
  46. O’Rahilly R, Müller F (2005) The embryonic human brain: an atlas of developmental stages, 3rd edn. Wiley, New YorkGoogle Scholar
  47. Ohm TG (2007) The dentate gyrus in Alzheimer’s disease. Progr Brain Res 163:723–740CrossRefGoogle Scholar
  48. Rauen T, Hedrich CM, Tenbrock K, Tsokos GC (2013) cAMP responsive element modulator: a critical regulator of cytokine production. Trends Mol Med. doi: 10.1016/j.molmed.2013.02.001
  49. Scott Bitner R (2012) Cyclic AMP response element-binding protein (CREB) phosphorylation: a mechanistic marker in the development of memory enhancing Alzheimer’s disease therapeutics. Biochem Pharmacol 83:705–714PubMedCrossRefGoogle Scholar
  50. Servillo G, Della Fazia MA, Sassone-Corsi P (1998) Transcription factor CREM coordinates the timing of hepatocyte proliferation in the regenerating liver. Genes Dev 12:3639–6943PubMedCrossRefGoogle Scholar
  51. Simón-Sánchez J, Schulte C, Bras JM, Sharma M, Gibbs JR, Berg D, Paisan-Ruiz C, Lichtner P, Scholz SW, Hernandez DG, Krüger R, Federoff M, Klein C, Goate A, Perlmutter J, Bonin M, Nalls MA, Illig T, Gieger C, Houlden H, Steffens M, Okun MS, Racette BA, Cookson MR, Foote KD, Fernandez HH, Traynor BJ, Schreiber S, Arepalli S, Zonozi R, Gwinn K, van der Brug M, Lopez G, Chanock SJ, Schatzkin A, Park Y, Hollenbeck A, Gao J, Huang X, Wood NW, Lorenz D, Deuschl G, Chen H, Riess O, Hardy JA, Singleton AB, Gasser T (2009) Genome-wide association study reveals genetic risk underlying Parkinson’s disease. Nat Genet 41:1308–1312PubMedCrossRefGoogle Scholar
  52. Smalmeiser NR, Lugli G (2009) microRNA regulation of synaptic plasticity. Neuromolecular Med 11:133–140CrossRefGoogle Scholar
  53. Stehle JH, Foulkes NS, Molina CA, Simonneaux V, Pévet P, Sassone-Corsi P (1993) Adrenergic signals direct rhythmic expression of transcriptional repressor CREM in the pineal gland. Nature 365(6444):314–320PubMedCrossRefGoogle Scholar
  54. Thal DR, Holzer M, Rüb U, Waldmann G, Günzel S, Zedlick D, Schober R (2000) Alzheimer-related tau pathology in the perforant path target zone and in the hippocampal stratum oriens and radiatum correlates with onset and degree of dementia. Exp Neurol 163:98–110PubMedCrossRefGoogle Scholar
  55. Uyttersprot N, Miot F (1997) Dog CREM transcription factors: cloning, tissue distribution, and identification of new isoforms. Biochem Biophys Res Commun 237:74–78PubMedCrossRefGoogle Scholar
  56. van Strien ME, van den Berge SA, Hol EM (2011) Migrating neuroblasts in the adult human brain: a stream reduced to a trickle. Cell Res 21:1523–1525PubMedCrossRefGoogle Scholar
  57. Wang A, Bibb JA (2011) Is CREB the angry bird that releases memory in Alzheimer’s? Neuropsychopharmacology 36:2153–2154PubMedCrossRefGoogle Scholar
  58. Wu X, Jin W, Liu X, Fu H, Gong P, Xu J, Cui G, Ng Y, Ke K, Gao Z, Gao Y (2012) Cyclic AMP response element modulator-1 (CREM-1) involves in neuronal apoptosis after traumatic brain injury. J Mol Neurosci 47:357–367PubMedCrossRefGoogle Scholar
  59. The Human Protein Atlas (Uppsala Universiteit). http://www.proteinatlas.org/
  60. Yamamoto-Sasaki M, Ozawa H, Saito T, Rösler M, Riederer P (1999) Impaired phosphorylation of cyclic AMP response element binding protein in the hippocampus of dementia of the Alzheimer type. Brain Res 824:300–303PubMedCrossRefGoogle Scholar
  61. Zhang X, Odom DT, Koo SH, Conkright MD, Canettieri G, Best J, Chen H, Jenner R, Herbolsheimer E, Jacobsen E, Kadam S, Ecker JR, Emerson B, Hogenesch JB, Unterman T, Young RA, Montminy M (2005) Genome-wide analysis of cAMP-response element binding protein occupancy, phosphorylation, and target gene activation in human tissues. Proc Natl Acad Sci USA 102:4459–4464PubMedCrossRefGoogle Scholar
  62. Zhu X, Han X, Blendy JA, Porter BE (2012) Decreased CREB levels suppress epilepsy. Neurobiol Dis 45:253–263PubMedCrossRefGoogle Scholar
  63. Zubenko GS, Maher B, Hughes HB 3rd, Zubenko WN, Stiffler JS, Kaplan BB, Marazita ML (2003) Genome-wide linkage survey for genetic loci that influence the development of depressive disorders in families with recurrent, early-onset, major depression. Am J Med Genet B Neuropsychiatr Genet 123B(1):1–18PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Wien 2013

Authors and Affiliations

  • Hans-Gert Bernstein
    • 1
    Email author
  • Elmar Kirches
    • 2
  • Bernhard Bogerts
    • 1
  • Uwe Lendeckel
    • 3
  • Gerburg Keilhoff
    • 4
  • Marina Zempeltzi
    • 1
  • Johann Steiner
    • 1
  • Klaus Tenbrock
    • 5
  • Henrik Dobrowolny
    • 1
  • Vasileios C. Kyttaris
    • 6
  • Christian Mawrin
    • 2
  1. 1.Department of PsychiatryOtto-von-Guericke-UniversityMagdeburgGermany
  2. 2.Departments of NeuropathologyOtto-von-Guericke-UniversityMagdeburgGermany
  3. 3.Department of Biochemistry and Molecular BiologyUniversity of GreifswaldGreifswaldGermany
  4. 4.Institute of Biochemistry and Cell BiologyOtto-von-Guericke-UniversityMagdeburgGermany
  5. 5.Department of PediatricsRWTH AachenAachenGermany
  6. 6.Division of Rheumatology, Beth Israel Deaconess Medical CenterHarvard Medical SchoolBostonUSA

Personalised recommendations